Biblio

Export 4 results:
Author Title Type [ Year(Asc)]
Filters: Author is Doran, Eric  [Clear All Filters]
2021
N. D. DiProspero, Keator, D. B., Phelan, M., van Erp, T. G. M., Doran, E., Powell, D. K., Van Pelt, K. L., Schmitt, F. A., Head, E., Lott, I. T., and Yassa, M. A., “Selective Impairment of Long-Range Default Mode Network Functional Connectivity as a Biomarker for Preclinical Alzheimer's Disease in People with Down Syndrome.”, J Alzheimers Dis, vol. 85, no. 1, pp. 153-165, 2021.
2017
E. Doran, Keator, D., Head, E., Phelan, M. J., Kim, R., Totoiu, M., Barrio, J. R., Small, G. W., Potkin, S. G., and Lott, I. T., “Down Syndrome, Partial Trisomy 21, and Absence of Alzheimer's Disease: The Role of APP.”, J Alzheimers Dis, vol. 56, no. 2, pp. 459-470, 2017.
P. Coskun, Helguera, P., Nemati, Z., Bohannan, R. C., Thomas, J., Samuel, S. E., Argueta, J., Doran, E., Wallace, D. C., Lott, I. T., and Busciglio, J., “Metabolic and Growth Rate Alterations in Lymphoblastic Cell Lines Discriminate Between Down Syndrome and Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 2, pp. 737-748, 2017.
M. S. Rafii, Skotko, B. G., McDonough, M. Ellen, Pulsifer, M., Evans, C., Doran, E., Muranevici, G., Kesslak, P., Abushakra, S., and Lott, I. T., “A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Oral ELND005 (scyllo-Inositol) in Young Adults with Down Syndrome without Dementia.”, J Alzheimers Dis, vol. 58, no. 2, pp. 401-411, 2017.